Breakthroughs in sending
the message
Some of the most fascinating biological processes, such as embryonic development, tissue regeneration and the physiological integration of body functions, rely on a network of cell–cell communication pathways.
Although the molecular players in cell–cell communication have long been known from genetic studies in model systems, many of the underlying mechanisms only now are beginning to be deciphered. Within this area, cell-surface receptors function like air-traffic controllers, integrating inputs from the cell’s exterior and interior to trigger signal transduction pathways, leading to specific cellular responses.
This track will focus on emerging mechanisms in cell-cell communication, particularly how cell-surface receptors interpret mechanical stimuli, how signaling molecules are controlled by less well understood post-translational modifications and how signaling polarizes cells and tissues. The track will showcase diverse modern approaches to understanding cell signaling, ranging from structural to organismal biology.
Keywords: mechanobiology, structural biology, post-translational modifications, signal transduction, receptors, ligands.
Who should attend: cell biologists, biochemists, structural biologists and developmental biologists, and particularly grad students and postdocs interested in emerging themes and state-of-the-art methodology in cell–cell signaling research.
Theme song: “Hotel California” by the Eagles. Once you come to our session, you will not want to leave.
This track is powered by communication.
Talks
- Piezo1 gains traction — Medha Pathak, University of California, Irvine
- Mechanotransduction in vascular health and disease — Martin Schwartz, Yale University
- Mechanical force and Notch signaling — Wendy Gordon, University of Minnesota
- Mechanisms linking mechanotransduction and cell metabolism — Kristin DiMali, University of Iowa
- Getting hedgehogs where they need to go — Stacey Ogden, St. Jude Children’s Research Hospital
- Rhomboid proteins in cell signaling — Matthew Freeman, University of Oxford
- Lipids and hedgehogs — Adrian Salic, Harvard Medical School
- Role of Notch glycosylation in signaling — Pamela Stanley, Albert Einstein College of Medicine
- Ligand engineering for probing receptor signaling mechanisms — Chris Garcia, Stanford University
- Cellular communication via adhesion — Demet Arac, University of Chicago
- Mechanisms of Wnt5a-Ror signaling in development and disease — Henry Ho, University of California, Davis
- Wnt/planar cell polarity signaling in skeletal development — Yingzi Yang, Harvard Dental School
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Careers
Careers highlights or most popular articles
Upcoming opportunities
Calling all biochemistry and molecular biology educators! Share your teaching experiences and insights in ASBMB Today’s essay series. Submit your essay or pitch by Jan. 15, 2026.

Mapping proteins, one side chain at a time
Roland Dunbrack Jr. will receive the ASBMB DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Exploring the link between lipids and longevity
Meng Wang will present her work on metabolism and aging at the ASBMB Annual Meeting, March 7-10, just outside of Washington, D.C.
Upcoming opportunities
Calling all biochemistry and molecular biology educators! Share your teaching experiences and insights in ASBMB Today’s essay series. Submit your essay or pitch by Jan. 15, 2026.

Defining a ‘crucial gatekeeper’ of lipid metabolism
George Carman receives the Herbert Tabor Research Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.